Redmile Group, LLC Replimune Group, Inc. Transaction History
Redmile Group, LLC
- $952 Million
- Q1 2025
A detailed history of Redmile Group, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 4,898,527 shares of REPL stock, worth $55.3 Million. This represents 5.02% of its overall portfolio holdings.
Number of Shares
4,898,527
Previous 4,905,527
0.14%
Holding current value
$55.3 Million
Previous $59.4 Million
19.6%
% of portfolio
5.02%
Previous 4.65%
Shares
25 transactions
Others Institutions Holding REPL
# of Institutions
170Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$125 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$122 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$53.2 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$44.1 Million9.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.83MShares$43.2 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $556M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...